Inside TumorSight Risk: What MRI-Based Recurrence Assessment Can and Cannot Tell Clinicians
Dr. Dereck Mush, MD, MBADr. Bobby Green
Co-Founder, President and Chief Medical Officer, Thyme Care
- Industry
- Value-based oncology care
- Based in
- Nashville, USA
- Company funding
- $300M raised
- Region
- North America
Medical oncologist and palliative care physician.
Shapes the clinical model behind Thyme Care's value-based cancer navigation platform.
[]
More founders in Value-based oncology care
- Robin Shah
Thyme Care
Related on The Signal
Dr. Dereck Mush, MD, MBA
Overcoming the Solvent Front: How Jideytro Validates Nuvalent's Precision Oncology Playbook
Dr. Dereck Mush, MD, MBA
Inside SimBioSys TumorSight Risk: Bringing Recurrence Assessment Into the MRI Workflow
Dr. Dereck Mush, MD, MBA
Reversing the Resistance Cascade: Vascular Reprogramming and Second-Line Antiandrogen Synergy
Dr. Dereck Mush, MD, MBAKeep exploring